Solstice (SOLS) reports tomorrow morning. Everyone's arguing about Element deal but there are two things in the filing I never see mentioned
Quick context: Solstice is the chemicals business Honeywell spun off last October. Refrigerants, pharma packaging film, armor fiber, plus the only plant in the US that converts uranium into the gas that gets enriched into reactor fuel. The stock ran to $88.60 by late June, mostly on excitement about that nuclear business. Then on July 6 they announced they're buying Element Solutions for $14.5 billion in borrowed cash and new shares, and the stock dropped 31% in six sessions. It's around $57 now and reports Q2 tomorrow before open, first print since the deal.
The bear case is real: Element's owners end up with about 44% of the combined company, leverage goes from \~1.4x EBITDA to \~3.5x at close on a $4.7 billion bridge loan, and an eight month old public company is buying something priced above its own market cap (\~$12.7 billion the day before the announcement). On top of that the refrigerant segment's margin has gone 39% to 35% to 34.1% over two years, the nuclear line actually had a down year in 2025 ($446M to $356M, the contracts are lumpy), and financing is not a condition of the deal, so they have to close whatever credit markets look like when the bridge comes due.
But I went through the whole paper trail: the merger agreement, the spin-off docs, the tax agreement with Honeywell, both annual reports. The $513 million detail below only turned up on a second pass through the merger agreement's fine print. Two things never come up in this debate.
One, the fixed exchange ratio everyone blames for the arb selling is actually a tax constraint. If 50% or more of a spun-off company changes hands as part of a connected plan, the spin turns retroactively taxable and the bill lands on Honeywell. Element's owners get 44%, deliberately under that line. And if Honeywell withdraws its consent under the separation tax agreement and there's no clean tax opinion, Element can walk away with $513 million, the largest termination fee in the agreement. The terms couldn't bend while the stock fell because part of the deal's structure still belongs to Honeywell.
Two, the nuclear business isn't fully theirs at the profit level. The plant sells everything through ConverDyn, a 50/50 JV with General Atomics, and the plant itself runs on cost recovery plus a minimum return, so the actual trading profit pools at the JV. You can see it in the "net income attributable to noncontrolling interest" line: $11M in 2024, $48M in 2025, $20M in Q1 2026 alone. Rough math, about a quarter of trailing net income went to the JV partner. So the nuclear upside gets halved at the JV, then diluted 44% by the deal.
Tomorrow I'm watching the refrigerant margin (stabilizing or new normal), whether nuclear revenue reaccelerates as old contracts reprice, and that noncontrolling interest line.
No position yet. Curious how others here read it: is the market right that the deal is the whole story, or is it repricing the bill and ignoring what the assets are?